Clinical trial
PhaseI Trial of Tumor Neoantigen Vaccine
NCT04087252 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PhaseI Trial of Tumor Neoantigen Vaccine
- Lead sponsor
- Henan Cancer Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 4, 2019
- Completion date
- December 30, 2021
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer